












Professor Rahim Horuz is a Turkish urologist with twenty years of experience as a specialist and active academic and clinical work at Medipol Mega University Hospital in Istanbul. He completed his urology residency at Istanbul Kartal Dr. Lütfi Kırdar Training and Research Hospital (2002–2006), and later served there as Deputy Chief of the Urology Department (2010–2012). Since 2012 he has been at Medipol Mega. His clinical focus is uro-oncology with the use of robotic surgery (the da Vinci system) for prostate cancer, reconstructive urology, endourology, and urolithiasis. He has more than 60 publications in peer-reviewed journals. In 2025 he is actively featured in the press as an expert in robotic urological surgery. According to patient reviews on independent platforms (an average rating of 5/5 across 14 reviews on Doktortakvimi and Doktorsitesi), he is distinguished by his empathy, thorough preparation of the patient for surgery, accessibility by phone and messengers, and successful robotic operations for prostate cancer with rapid recovery. For the patient, this is an opportunity to undergo a robotic or endoscopic operation by a professor with a confirmed clinical and patient reputation in one of the most technologically advanced university clinics in Istanbul.
Urology. Clinical areas: uro-oncology (including prostate cancer, kidney cancer, bladder cancer), reconstructive urology, robotic surgery, endourology, urolithiasis, minimally invasive urology. Also — varicocele, microsurgical sperm retrieval, prostatitis.


Medipol Mega University Hospital is a university clinical complex that combines four specialized hospitals under one roof: general, oncology, cardiac surgery, and dental. The clinic holds international JCI accreditation, including a separate academic accreditation for university medical centers (the first in Turkey under this standard). It runs a robotic surgery program (the da Vinci system) in urology, cardiac surgery, gynecology, and general surgery, as well as high-intensity focused ultrasound (HIFU) technology for the treatment of prostate cancer, uterine fibroids, and bone metastases. The oncology hospital within the complex operates as a separate specialized facility with multidisciplinary tumor boards. For a patient with a uro-oncological diagnosis, urolithiasis, or prostate adenoma, this means the opportunity to go through the full path — from diagnosis and multidisciplinary discussion to robotic or endoscopic surgery and postoperative follow-up — in a university clinic with international accreditation and a modern technological base.
